The company is committed to using high-tech means to achieve rational development and sustainable development of rare natural resources, achieve value innovation in traditional industries under the guidance of innovative theory, and provide consumers with excellent quality and more valuable products. Under the guidance of the “double activation” health brewing theory, the company's Tsinghua Liquor series products use targeted bacteria and new harm-reduction and benefit-reduction processes such as secondary fermentation and distillation and concentration to rebrew old alcoholic wines to achieve a leap forward in wine value: upgrading flavor and taste and innovating value after drinking. The company's main business includes two major aspects. One is the liquor FMCG business segment, which mainly sells alcoholic beverages products, and the other is the big health business segment, which focuses on R&D, production and sales of Cordyceps sinensis products. Main products: High-end liquor, Cordyceps sinensis, traditional Chinese medicine products with Cordyceps sinensis as the main ingredient.